Cargando…

Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly

OBJECTIVE: Higher levels of the novel inflammatory marker pentraxin 3 (PTX3) predict cardiovascular mortality in patients with chronic kidney disease (CKD). Yet, whether PTX3 predicts worsening of kidney function has been less well studied. We therefore investigated the associations between PTX3 lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sjöberg, B., Qureshi, A. R., Heimbürger, O., Stenvinkel, P., Lind, L., Larsson, A., Bárány, P., Ärnlöv, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737281/ https://www.ncbi.nlm.nih.gov/pubmed/26355706 http://dx.doi.org/10.1111/joim.12411

Ejemplares similares

Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
por: Sjöberg, Bodil, et al.
Publicado: (2014)

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients
por: Dai, Lu, et al.
Publicado: (2017)

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
por: Missailidis, Catharina, et al.
Publicado: (2016)

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
por: Machowska, Anna, et al.
Publicado: (2016)

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients
por: Li, Xiejia, et al.
Publicado: (2023)

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease
por: Mukai, Hideyuki, et al.
Publicado: (2018)

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
por: Golembiewska, Edyta, et al.
Publicado: (2020)

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
por: Alves, Filipa Caeiro, et al.
Publicado: (2018)

Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy
por: Witasp, Anna, et al.
Publicado: (2022)

Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction
por: Witasp, Anna, et al.
Publicado: (2013)

Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
por: Hernandez, Leah, et al.
Publicado: (2022)

Longitudinal effects of aging on plasma proteins levels in older adults – associations with kidney function and hemoglobin levels
por: Lind, Lars, et al.
Publicado: (2019)

High-sensitivity troponins in dialysis patients: variation and prognostic value
por: Snaedal, Sunna, et al.
Publicado: (2020)

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
por: Feldreich, Tobias, et al.
Publicado: (2018)

Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
por: Ryu, Kakei, et al.
Publicado: (2023)

Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study
por: Dai, Lu, et al.
Publicado: (2021)

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
por: Chen, Zhimin, et al.
Publicado: (2019)

Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes
por: Tonkonogi, Aleksandra, et al.
Publicado: (2016)

Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients
por: Danielson, Kristin, et al.
Publicado: (2014)

Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
por: Meuwese, Christiaan Lucas, et al.
Publicado: (2015)

Serum pentraxin 3 concentrations in neonates
por: Lannergård, Anders, et al.
Publicado: (2014)

Evaluation of the Association of Plasma Pentraxin 3 Levels with Type 2 Diabetes and Diabetic Nephropathy in a Malay Population
por: Abu Seman, Norhashimah, et al.
Publicado: (2013)

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
por: Pei, Ming, et al.
Publicado: (2019)

Association between Plasma Pentraxin 3 Levels and Bone Mineral Density in Elderly Koreans: the Dong-gu Study
por: Lee, Ran, et al.
Publicado: (2018)

Usefulness of Plasma Pentraxin 3 Levels in Acute and Chronic Inflammatory Diseases
por: Han, Sang Hoon
Publicado: (2018)

Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
por: Chesnaye, Nicholas C., et al.
Publicado: (2019)

The association between glomerular filtration rate and left ventricular function in two independent community-based cohorts of elderly
por: Nerpin, Elisabet, et al.
Publicado: (2014)

Genetically Predicted Circulating Copper and Risk of Chronic Kidney Disease: A Mendelian Randomization Study
por: Ahmad, Shafqat, et al.
Publicado: (2022)

Proteins associated with incident metabolic syndrome in population-based cohorts
por: Lind, Lars, et al.
Publicado: (2021)

The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease
por: Marschner, Julian A., et al.
Publicado: (2018)

Aerobic Training Down-Regulates Pentraxin 3 and Pentraxin 3/Toll-Like Receptor 4 Ratio, Irrespective of Oxidative Stress Response, in Elderly Subjects
por: Estébanez, Brisamar, et al.
Publicado: (2020)

Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
por: Dai, Lu, et al.
Publicado: (2019)

Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project
por: Gasparini, Alessandro, et al.
Publicado: (2019)

Plasma Protein Profile of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure in 2 Cohorts
por: Lind, Lars, et al.
Publicado: (2021)

Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease
por: Carracedo, M., et al.
Publicado: (2019)

Insights into the Relationship between Pentraxin-3 and Cancer
por: Bogdan, Maria, et al.
Publicado: (2022)

Higher Pentraxin-3 Level in Patients with Metabolic Syndrome
por: Balta, Sevket, et al.
Publicado: (2013)

CDKN2A/p16INK4(a) expression is associated with vascular progeria in chronic kidney disease
por: Stenvinkel, Peter, et al.
Publicado: (2017)

Large‐Scale Metabolomics and the Incidence of Cardiovascular Disease
por: Lind, Lars, et al.
Publicado: (2023)

Regulation of pentraxin-3 by antioxidants
por: Hill, A. L., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_oi7f6v7947ref7m3j92bq2ojfd